B7-H4LG--A NOVEL CO-INHIBITORY AGENT FOR THE TREATMENT OF AUTOIMMUNE PANCREATITIS

$115,945FY2012Department of the ArmyDOD

Medimmune Biologics, Inc.

Investigators

View source on USAspending →